TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Macopharma Nordic AB
Closing information (x1000 NOK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
38,709
|
43,036
|
50,864 |
Financial expenses |
292
|
673
|
134 |
Earnings before taxes |
62
|
1,019
|
950 |
EBITDA |
3,666
|
4,314
|
2,584 |
Total assets |
20,283
|
23,486
|
22,350 |
Current assets |
10,929
|
13,352
|
13,603 |
Current liabilities |
5,273
|
6,084
|
8,206 |
Equity capital |
14,230
|
13,230
|
13,539 |
- share capital |
101
|
95
|
98 |
Employees (average) |
8
|
9
![]() |
9 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
70.2%
|
56.3%
|
60.6% |
Turnover per employee |
4,839
|
4,782
|
5,652 |
Profit as a percentage of turnover |
0.2%
|
2.4%
|
1.9% |
Return on assets (ROA) |
1.7%
|
7.2%
|
4.9% |
Current ratio |
207.3%
|
219.5%
|
165.8% |
Return on equity (ROE) |
0.4%
|
7.7%
|
7.0% |
Change turnover |
-7,381
|
-6,299
|
1,689 |
Change turnover % |
-16%
|
-13%
|
3% |
Chg. No. of employees |
-1
|
0
![]() |
0 |
Chg. No. of employees % |
-11%
|
0%
![]() |
0% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.